Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Capital Employed (2024 - 2025)

CG Oncology (CGON) has disclosed Return on Capital Employed for 2 consecutive years, with 0.26% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 8.0% year-over-year to 0.26%, compared with a TTM value of 0.26% through Dec 2025, down 8.0%, and an annual FY2025 reading of 0.26%, down 1.0% over the prior year.
  • Return on Capital Employed was 0.26% for Q4 2025 at CG Oncology, up from 0.26% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.15% in Q2 2024 and bottomed at 0.26% in Q3 2025.